Ziltivekimab
Ziltivekimab is a monoclonal antibody under investigation for its potential to reduce cardiovascular risk. This tag covers articles focusing on ziltivekimab's efficacy, trials, and related cardiovascular health impacts.
Ziltivekimab is a monoclonal antibody under investigation for its potential to reduce cardiovascular risk. This tag covers articles focusing on ziltivekimab's efficacy, trials, and related cardiovascular health impacts.
